GGrantIndex
Sort

130,381 grants matching hiv

Focal Segmental Glomerulosclerosis: Genetics & Mechanisms

$1,827,056
Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Focal Segmental Glomerulosclerosis: Genetics & Mechanisms

$1,827,056
Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Molecular Biology Of Retroviruses Associated With AIDS

$1,827,011
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

ADULT AIDS CLINICAL TRIALS UNIT

$1,826,895
Washington University · U01 · FY2005 · AI

Macrophage Targeted Therapy for HAD and HIV Disease

$1,826,730
Michael Shannon McGrath · University Of California, San Francisco · U19 · FY2011 · MH

Primate Lentivirus Pathogenesis

$1,826,463
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Molecular Genetics Of Eukaryotic Cells And Their Viruses

$1,826,463
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Use of Focused ultrasound stimulated blood brain barrier opening for CNS HIV/SIV reservoir reduction

$1,825,990
Mahesh Mohan · Texas Biomedical Research Institute · R01 · FY2025 · DA

The Ohio State University AIDS Clinical Trials Unit

$1,825,977
Susan L Koletar · Ohio State University · U01 · FY2007 · AI

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS

$1,825,789
Michael S. Saag · University Of Alabama At Birmingham · R24 · FY2009 · AI

IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM

$1,825,711
Thomas Denny · Duke University · N01 · FY2023 · AI

MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)

$1,825,475
Pamina Mae Gorbach · University Of California Los Angeles · U01 · FY2021 · DA

Mucosal Immune Barrier in Infection and Immunity

$1,825,211
Keith E. Mostov · University Of California, San Francisco · P01 · FY2008 · AI

Programatic-Strengthening Medical Education for Improved Health Outcomes in Kenya

$1,825,000
James Njogu Kiarie · University Of Nairobi · R24 · FY2012 · TW

Project 3- Mucosal Determinants of Virus Transmission

$1,824,620
Guido Silvestri · University Of Maryland Baltimore · P01 · FY2019 · AI

ADULT AIDS CLINICAL TRIALS UNIT

$1,824,091
Washington University · U01 · FY2004 · AI

PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA

$1,823,377
Johns Hopkins University · R01 · FY2002 · AI

Age-17 Follow-up of Home Visiting Intervention

$1,823,169
David L Olds · University Of Rochester · R01 · FY2008 · DA

MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN

$1,822,294
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · P01 · FY2010 · HD

ARV effects on HIV epidemiology and behaviors in Rakai, Uganda

$1,822,150
Maria J Wawer · Johns Hopkins University · R01 · FY2009 · HD

Center for Experimental Infectious Disease Research

$1,822,027
Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2006 · RR

Penn mental health AIDS research center

$1,821,936
Dwight L. Evans · University Of Pennsylvania · P30 · FY2021 · MH

NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities

$1,821,904
Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI

AIDS CLINICAL TRIALS GROUP - ACTU

$1,821,879
University Of Cincinnati · U01 · FY2003 · AI

HIV VACCINE CLINICAL TRIALS UNIT

$1,821,839
Vanderbilt University · U01 · FY2002 · AI